The ovarian follicles generate the hormone known as AMH (Anti-Müllerian hormone). The
hormone AMH shows higher levels in patients who have polycystic ovary syndrome (PCOS).
The research investigates the connection between AMH hormone levels in PCOS patients
through hormone analysis of women with the syndrome versus a control group. AMH levels are
measured to assess the ovary's capacity to generate eggs, which is advantageous for reproductive
treatments, and to diagnose PCOS by identifying an increased number of tiny follicles. The
current study included 90 Iraqi women (aged 18-40 years): 46 with PCOS and a control group of
44 healthy women. Blood samples were taken from the study participants to evaluate the levels
of certain hormones, including AMH, LH, E2, insulin. Blood samples were collected during the
early follicular phase of the menstrual cycle (days 2–5) to ensure hormonal consistency. The
following parameters were studied: AMH levels were significantly elevated in both normal
weight and overweight/obese PCOS women compared to their respective control groups. This is
a hallmark of PCOS, reflecting increased ovarian follicle count. AMH levels (ng/ml) were
significantly higher in women with PCOS compared to normal weight controls (p = 0.015),
indicating a strong association between elevated AMH and PCOS